CIA
PRCT icon

Cape Investment Advisory’s Procept Biorobotics PRCT Stock Holding History

Cape Investment Advisory’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15
Closed -$472 – 930
2025
Q4 		$472 Hold
15
– – ﹤0.01% 1249
2025
Q3 		$535 Buy
15
+1
+7% +$46 ﹤0.01% 778
2025
Q2 		$806 Buy
+14
New +$792 ﹤0.01% 1053

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cape Investment Advisory's PRCT Position: Q1 2026 in Review

Cape Investment Advisory sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 15 shares — an estimated $472 sold.

Cape Investment Advisory first reported a position in PRCT in Q2 2025 and held it in 3 quarters. The position peaked at $806 in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Cape Investment Advisory reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Cape Investment Advisory sold 15 Procept Biorobotics shares in Q1 2026, an estimated $472.
  • Cape Investment Advisory first reported a position in Procept Biorobotics in Q2 2025 and held it in 3 quarters.
  • Cape Investment Advisory's Procept Biorobotics position peaked at $806 in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Cape Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.